New Delhi: India’s first indigenously-developed vaccine for prevention of cervical cancer will be launched here on Thursday.
Drugs Controller General of India (DCGI) last month granted market authorization to Serum Institute of India (SII) to manufacture the quadrivalent Human Papilloma Virus (HPV) vaccine.
Union Minister of Science and Technology Jitendra Singh will launch the vaccine at IIC Delhi, in the presence of SII CEO Adar Poonawalla, PTI reported.
According to officials, the qHPV vaccine CERVAVAC has shown robust antibody response which is nearly 1,000 times higher than the baseline against all targeted HPV types, and in all dose and age groups.
Cervical cancer is the second most common form of cancer among women in the 15-44 age group, after breast cancer.
Mumbai: From tidbits about their married life to her husband's acting career, Govinda's wife Sunita…
Bhubaneswar: The Odisha government will run premium buses from different places in the state to…
Bhubaneswar: Union Minister of Youth Affairs & Sports Mansukh Mandaviya inaugurated a cycling velodrome at…
Malkangiri: Robbers struck at a shop and reportedly took away mobile phones worth over Rs…
Kochi: A popular annual festival at a mosque in Kerala’s Malappuram district turned chaotic after…
Bhubaneswar: Prime Minister Narendra Modi arrived in Bhubaneswar on Wednesday night to attend the 18th…
This website uses cookies.
